Previous Page  9 / 10 Next Page
Information
Show Menu
Previous Page 9 / 10 Next Page
Page Background

Page 45

Notes:

Journal of Biotechnology & Biomaterials | ISSN: 2155-952X | Volume: 8

July 23-24, 2018 | Vancouver, Canada

Annual Biotechnology Congress

Electronic water can reduce oxidative stress in cancer and diabetes patients for three weeks drinking

O

xidative stress means a state there is imbalance between the oxidizing action and the reducing action due to reactive oxygen

species (ROS) in a living body, resulting in the oxidizing action becoming dominant. Oxidative stress arises as the balance

between production and removal is disrupted through excessive production of ROS and impairment of the antioxidant system.

Oxidative stress has been reported to be involved in the onset and progress of various diseases. Characteristics of type 2 diabetes

are insulin secretion failure and insulin resistance, but it seems that oxidative stress is greatly involved in insulin secretion

failure. In the insulin secretion-inducing β cells of Langerhans islets in the pancreas, the amount of superoxide dismutase

(SOD), which is representative of the ROS elimination system, is small and resistance to oxidative stress is weak. Regarding

cancer, it is well known that chronic inflammatory conditions increase the risk of carcinogenesis. Cells such as neutrophils and

macrophages are activated in the inflammation area leading to increase in production of active oxygen and nitric oxide. These

free radicals cause DNA mutation and cell proliferation thereby promoting cancer development. When chronic inflammation

is present, cancer develops more easily. Electronic water, which was developed to generate electron in water, was consumed for

three weeks, after meals, between meals and before sleeping six times a day, and according to the test subjects' possible time

periods. The amount of drinking water was 750-1000 mL, and BAP and d-ROMs checks for all cases were carried out at 4:30

pm. The results of cancer patients and diabetes patients were attached. As a result, the d-ROMs value in the degree of oxidative

stress has reduced, and the BAP value, which is an indicator of plasma antioxidant capacity, has improved significantly.

Biography

Masahiro Onuma has expertise in oxidative disease prevention to use non-medical product based on GSK’s experience of allopurinol which has the strongest

anti-oxidant efficacy in this world. He creates new indication of allopurinol for stomatitis induced by cancer treatment which was approved by the Japanese cancer

treatment committee to propose new mechanism of allopurinol for anti-oxidant. And now, there are so many new research papers of allopurinol in the world.

onuma@trisguide.com

Masahiro Onuma

Trisguide Ltd, Japan

Masahiro Onuma, J Biotechnol Biomater 2018, Volume: 8

DOI: 10.4172/2155-952X-C3-093